KR101521123B1 - 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드 - Google Patents

프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드 Download PDF

Info

Publication number
KR101521123B1
KR101521123B1 KR1020087031307A KR20087031307A KR101521123B1 KR 101521123 B1 KR101521123 B1 KR 101521123B1 KR 1020087031307 A KR1020087031307 A KR 1020087031307A KR 20087031307 A KR20087031307 A KR 20087031307A KR 101521123 B1 KR101521123 B1 KR 101521123B1
Authority
KR
South Korea
Prior art keywords
delete delete
st4sa
strain
peptide
enterococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020087031307A
Other languages
English (en)
Korean (ko)
Other versions
KR20090023626A (ko
Inventor
레온 밀너 테오도르 딕
스베토슬라브 디미트로브 토도로브
헨드리에테 크노에츠
마렐리제 브링크
Original Assignee
시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA200604035A external-priority patent/ZA200604035B/xx
Application filed by 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 filed Critical 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디
Publication of KR20090023626A publication Critical patent/KR20090023626A/ko
Application granted granted Critical
Publication of KR101521123B1 publication Critical patent/KR101521123B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020087031307A 2006-05-28 2007-05-25 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드 Expired - Fee Related KR101521123B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA200604035A ZA200604035B (en) 2005-05-31 2006-05-28 Improved grenade launcher
ZA2006/04035 2006-05-28
PCT/IB2007/051982 WO2007138538A2 (en) 2006-05-28 2007-05-25 Probiotic strain and antimicrobial peptide derived therefrom

Publications (2)

Publication Number Publication Date
KR20090023626A KR20090023626A (ko) 2009-03-05
KR101521123B1 true KR101521123B1 (ko) 2015-05-19

Family

ID=38779065

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087031307A Expired - Fee Related KR101521123B1 (ko) 2006-05-28 2007-05-25 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드

Country Status (13)

Country Link
US (2) US7951385B2 (https=)
EP (1) EP2021457B1 (https=)
JP (1) JP2009538614A (https=)
KR (1) KR101521123B1 (https=)
CN (1) CN101454440B (https=)
AP (1) AP2841A (https=)
AU (1) AU2007266675B2 (https=)
CA (1) CA2647161A1 (https=)
EA (1) EA017558B1 (https=)
IL (2) IL195520A0 (https=)
NO (1) NO20084577L (https=)
NZ (1) NZ571619A (https=)
WO (1) WO2007138538A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101722255B1 (ko) * 2016-04-22 2017-04-03 주식회사 폴인브레드 쌀과 쌀누룩을 이용한 자연발효종 제조방법
KR102076089B1 (ko) 2018-10-02 2020-02-11 서울대학교 산학협력단 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp)
WO2024155017A1 (ko) * 2023-01-18 2024-07-25 조선대학교산학협력단 오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101521123B1 (ko) * 2006-05-28 2015-05-19 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드
US8357519B2 (en) * 2008-11-19 2013-01-22 The Ohio State University Methods and processes for producing esters
WO2011045764A1 (en) * 2009-10-15 2011-04-21 Cipla Medpro Research And Development (Pty) Ltd A product for delivering antimicrobially active substances to an infected site
JP5881017B2 (ja) * 2010-11-05 2016-03-09 国立大学法人広島大学 籾殻または玄米から単離された植物乳酸菌およびその利用
WO2012148891A1 (en) * 2011-04-29 2012-11-01 Evonik Degussa Corporation Peptide-lipid conjugates and uses thereof
RU2532227C1 (ru) * 2013-10-23 2014-10-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью
RU2599430C1 (ru) * 2015-07-23 2016-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ
US9944960B2 (en) * 2015-11-17 2018-04-17 Premier Research Labs, Lp Process for microbial production of dihydrolipoic acid and extraction of dihydrolipoic acid with edible oils
CN105385636A (zh) * 2015-12-07 2016-03-09 江南大学 一株产细菌素的肠膜明串珠菌及其应用
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
AU2018336988B2 (en) * 2017-09-19 2023-06-22 Advaxis, Inc. Compositions and methods for lyophilization of bacteria or Listeria strains
WO2019151371A1 (ja) * 2018-01-31 2019-08-08 ニュートリー株式会社 肺炎球菌感染症の予防及び／又は治療剤
CN109456911B (zh) * 2018-10-10 2019-10-18 南京林业大学 一株蒙氏肠球菌HcM7及其应用
CN110846260B (zh) * 2019-12-18 2021-03-02 江南大学 一株降低生物胺的肉葡萄球菌及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1084969A (ja) 1996-09-19 1998-04-07 Chemo Sero Therapeut Res Inst ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
US7655775B2 (en) * 1997-09-05 2010-02-02 Canbiocin, Inc. Expression vectors for treating bacterial infections
AU7898700A (en) 1999-10-22 2001-05-08 Shanghai Bio Road Gene Development Ltd. A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
GB0125535D0 (en) 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US6878373B2 (en) 2001-12-03 2005-04-12 Micropure Technologies, Inc. Probiotic composition containing Bacillus cereus RRRL B-30535
JP4111489B2 (ja) * 2002-05-23 2008-07-02 プリマハム株式会社 新規バクテリオシン
WO2004005492A2 (fr) * 2002-07-03 2004-01-15 Galina Gennadievna Alekhina Composition probiotique a base d'une souche d'enterocoques pour moyens de traitement et de prevention et procede de fabrication correspondant
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ITBO20020564A1 (it) 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
KR101521123B1 (ko) * 2006-05-28 2015-05-19 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Appl. Environ. Microbiol. August 2002, vol. 68, no. 8, pages 3830-3840. *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101722255B1 (ko) * 2016-04-22 2017-04-03 주식회사 폴인브레드 쌀과 쌀누룩을 이용한 자연발효종 제조방법
KR102076089B1 (ko) 2018-10-02 2020-02-11 서울대학교 산학협력단 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp)
WO2024155017A1 (ko) * 2023-01-18 2024-07-25 조선대학교산학협력단 오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도

Also Published As

Publication number Publication date
AU2007266675A1 (en) 2007-12-06
AU2007266675B2 (en) 2012-09-06
US20110268703A1 (en) 2011-11-03
AP2841A (en) 2014-02-28
AP2008004626A0 (en) 2008-10-31
US20090297482A1 (en) 2009-12-03
CA2647161A1 (en) 2007-12-06
US8444998B2 (en) 2013-05-21
NO20084577L (no) 2008-12-19
EP2021457B1 (en) 2015-02-11
NZ571619A (en) 2011-10-28
IL195520A0 (en) 2011-08-01
WO2007138538A3 (en) 2008-04-17
IL250634A0 (en) 2017-03-30
EA017558B1 (ru) 2013-01-30
KR20090023626A (ko) 2009-03-05
EA200802409A1 (ru) 2009-10-30
CN101454440A (zh) 2009-06-10
US7951385B2 (en) 2011-05-31
WO2007138538A2 (en) 2007-12-06
EP2021457A2 (en) 2009-02-11
CN101454440B (zh) 2013-05-29
JP2009538614A (ja) 2009-11-12

Similar Documents

Publication Publication Date Title
KR101521123B1 (ko) 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드
US12599637B2 (en) Genetically modified Lactobacillus and uses thereof
EP1002051B1 (en) Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
KR102024883B1 (ko) 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
JP2009545311A (ja) 人間母乳から分離したプロバイオティック活性、及び体重増加抑制活性を有する乳酸菌
EP0760848A1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
WO2001000045A1 (en) Drinks and foods capable of eliminating helicobacter pylori
KR101310123B1 (ko) 헬리코박터 파이로리의 생육을 저해하는 김치 유래 젖산균
US20070134220A1 (en) Lactobacillus fermentum strain and uses thereof
JP4509250B2 (ja) Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性医薬品
CN114574405A (zh) 植物乳杆菌菌株wka86及其在制备防治口臭制品方面的用途与制品
KR101364695B1 (ko) 헬리코박터 파이로리의 생육을 저해하는 타락 유래 젖산균
JP2004519236A (ja) ビフィドバクテリウム由来の新規なプラスミド、これを利用した組換え発現ベクターおよび形質転換方法
KR100646938B1 (ko) 헬리코박터 필로리의 정착과 생육 활성을 저해하는락토바실루스 람노서스 아이디씨씨 3201
EP1148064A1 (en) Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori
AU2024201593B2 (en) A genetically modified Lactobacillus and uses thereof
MX2008013429A (es) Cepas novedosas de enterococcus y streptococcus y bacteriocinas.
NAGAMANI THESIS SUBMITTED TO THE
PANWAR Production and purification of native and recombinant surface layer protein (S-layer protein) from probiotic Lactobacillus spp.

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180513

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180513